COVID-19 Treatment: Cipla to manufacture and sell Eli Lilly's baricitinib in India - Coronavirus Updates

To treat COVID-19 patients, US Food and Drug Administration gave Eli Lilly an emergency use approval for baricitinib in combination with remdesivir last year

Read More >>